A prespecified analysis of the MASTER DAPT trial has confirmed that the absence of ischemic risk and reduction in bleeding with abbreviated dual antiplatelet therapy (DAPT) […]
The known benefits of statin therapy in preventing cardiovascular disease, including heart attacks and strokes, outweigh the slightly increased risk of muscle symptoms, according to late […]
A phase 2 trial in patients with a prior ischemic stroke or high-risk transient ischemic attack (TIA) has indicated that milvexian should be further investigated for […]